Photocure - Asset Resilience Ratio

Latest as of September 2025: 35.56%

Photocure (PHO) has an Asset Resilience Ratio of 35.56% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Photocure (PHO) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Nkr247.77 Million

≈ $26.07 Million USD Cash + Short-term Investments

Total Assets

Nkr696.70 Million

≈ $73.31 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2024)

This chart shows how Photocure's Asset Resilience Ratio has changed over time. See Photocure shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Photocure's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Photocure market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Nkr247.77 Million	35.56%
Short-term Investments	Nkr0.00	0%
Total Liquid Assets	Nkr247.77 Million	35.56%

Asset Resilience Insights

Very High Liquidity: Photocure maintains exceptional liquid asset reserves at 35.56% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Photocure Industry Peers by Asset Resilience Ratio

Compare Photocure's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for Photocure (2000–2024)

The table below shows the annual Asset Resilience Ratio data for Photocure.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	39.08%	Nkr288.83 Million ≈ $30.39 Million	Nkr739.09 Million ≈ $77.77 Million	+3.08pp
2023-12-31	36.00%	Nkr256.34 Million ≈ $26.97 Million	Nkr711.97 Million ≈ $74.92 Million	-0.80pp
2022-12-31	36.81%	Nkr264.65 Million ≈ $27.85 Million	Nkr719.03 Million ≈ $75.66 Million	-3.60pp
2021-12-31	40.40%	Nkr319.04 Million ≈ $33.57 Million	Nkr789.65 Million ≈ $83.09 Million	-2.06pp
2020-12-31	42.46%	Nkr329.53 Million ≈ $34.68 Million	Nkr776.05 Million ≈ $81.66 Million	-4.63pp
2019-12-31	47.10%	Nkr121.20 Million ≈ $12.75 Million	Nkr257.35 Million ≈ $27.08 Million	-31.46pp
2018-12-31	78.56%	Nkr181.62 Million ≈ $19.11 Million	Nkr231.20 Million ≈ $24.33 Million	-7.45pp
2017-12-31	86.00%	Nkr226.28 Million ≈ $23.81 Million	Nkr263.10 Million ≈ $27.69 Million	+84.36pp
2015-12-31	1.64%	Nkr4.08 Million ≈ $428.81K	Nkr248.06 Million ≈ $26.10 Million	+0.17pp
2014-12-31	1.48%	Nkr4.00 Million ≈ $420.39K	Nkr270.58 Million ≈ $28.47 Million	+1.44pp
2013-12-31	0.04%	Nkr117.00K ≈ $12.31K	Nkr301.73 Million ≈ $31.75 Million	-0.94pp
2012-12-31	0.98%	Nkr4.24 Million ≈ $446.49K	Nkr432.98 Million ≈ $45.56 Million	+0.18pp
2011-12-31	0.80%	Nkr4.09 Million ≈ $430.81K	Nkr509.18 Million ≈ $53.58 Million	-66.19pp
2010-12-31	66.99%	Nkr344.24 Million ≈ $36.22 Million	Nkr513.84 Million ≈ $54.07 Million	-16.26pp
2009-12-31	83.25%	Nkr380.33 Million ≈ $40.02 Million	Nkr456.86 Million ≈ $48.08 Million	+82.01pp
2008-12-31	1.24%	Nkr2.94 Million ≈ $309.69K	Nkr237.85 Million ≈ $25.03 Million	+0.30pp
2007-12-31	0.94%	Nkr2.82 Million ≈ $296.96K	Nkr301.39 Million ≈ $31.72 Million	-55.04pp
2005-12-31	55.98%	Nkr59.17 Million ≈ $6.23 Million	Nkr105.70 Million ≈ $11.12 Million	-11.23pp
2004-12-31	67.20%	Nkr116.74 Million ≈ $12.28 Million	Nkr173.71 Million ≈ $18.28 Million	-6.68pp
2003-12-31	73.88%	Nkr172.44 Million ≈ $18.15 Million	Nkr233.40 Million ≈ $24.56 Million	+1.12pp
2002-12-31	72.76%	Nkr217.55 Million ≈ $22.89 Million	Nkr299.01 Million ≈ $31.46 Million	-16.58pp
2001-12-31	89.34%	Nkr285.49 Million ≈ $30.04 Million	Nkr319.57 Million ≈ $33.63 Million	-1.80pp
2000-12-31	91.13%	Nkr368.95 Million ≈ $38.82 Million	Nkr404.85 Million ≈ $42.60 Million	--

pp = percentage points

About Photocure

OL:PHO Norway Drug Manufacturers - Specialty & Generic

Market Cap

$184.23 Million

Nkr1.75 Billion NOK

Market Cap Rank

#16846 Global

#138 in Norway

Share Price

Nkr65.80

Change (1 day)

-0.75%

52-Week Range

Nkr49.40 - Nkr79.00

All Time High

Nkr150.90